Professional
Added to YB: 2026-07-07
Pitch date: 2026-03-31
GH [bullish]
Guardant Health, Inc.
+75.31%
current return
Author Info
No bio for this author
Company Info
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
Market Cap
$22.3B
Pitch Price
$96.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
-61.19
P/E
-49.33
EV/Sales
21.18
Sector
Health Care Providers and Services
Category
growth
Baron Health Care Fund New Position: Guardant Health, Inc.
GH (new position): Diagnostics co w/ liquid biopsy tests. Guardant360 leads $10B therapy selection mkt; Reveal ($20B MRD/recurrence); Shield colorectal screening ($18B) beating expectations, expanding sales force 300→600 via Quest partnership. 33% rev growth 2025, guiding 27-30% 2026. $1.3B cash, targeting FCF breakeven Q4 2027.
Read full article (2 min)